Zai Lab
China-focused in-licensing and development specialist that bridges western innovation into China. Partners with GSK, Novartis, Incyte and others. Zejula (niraparib) is its lead oncology asset. Dual-listed NASDAQ (ZLAB) and HKEX (9688.HK). Strategy centers on acquiring Greater China rights to western drugs.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Small-cell Lung Cancer
A Study of ZL-1310 in Subjects With Small Cell Lung CancerPhase 1 · Recruiting · SCLC
A Study of ZL-1310 in Participants With Selected Solid TumorsPhase 1 · Recruiting · Solid Tumors
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic DermatitisPhase 1 · Recruiting · Atopic Dermatitis (AD)
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected TumorsPhase 1 · Recruiting · Solid Tumors
A Study of ZL-1310 in Combination With a Checkpoint Inhibitor Versus Standard of Care Platinum Based Chemotherapy With a Checkpoint Inhibitor as First-line Therapy in Participants With Extensive-Stage Small Cell Lung CancerPhase 3 · Not Yet Recruiting · Extensive-Stage Small Cell Lung Cancer
Selected patent records
niraparib tosylate · Expires 2027-08-12
US 8143241niraparib tosylate · Expires 2027-08-12
US 10124014omadacycline tosylate · Expires 2029-03-05
US 9724358omadacycline tosylate · Expires 2029-03-05
US 8436185niraparib tosylate · Expires 2029-04-24
US 8383610omadacycline tosylate · Expires 2030-09-23
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/zai-lab/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.